Hospitals wary of FDA guidance on plasma treatments for coronavirus
Doctors are considering joining a clinical trial to test the effectiveness of convalescent plasma treatment against the coronavirus rather than relying on government guidance that allows a broader emergency use of the technique right now.
Despite the Food and Drug Administration’s permission in August to use convalescent plasma on COVID-19 patients, doctors remain concerned that science doesn’t fully back the effectiveness of the treatment and worry that President Trump pressured the agency into approving its usage.
Trump praised the “powerful therapy,” which has been administered to more than 77,000 COVID-19 patients in the U.S., but scientists from the National Institutes of Health declared that it “should not be considered the standard of care for the treatment of patients with COVID-19,” and pushed for more testing.
Data so far suggests the treatment could be beneficial, but it’s not definitive.
“It’s an important …continued .
[Source: Fox News]